Home › NCT07657104

Developing and Implementing HPV SCREENED

Developing and Implementing HPV SCREENED (Self-Collection REach and ENgagement in Emergency Departments) to Improve Cancer Equity

Who can join

Ages 30 to 65 · Women · Healthy volunteers welcome

Inclusion Criteria:

* biological women,
* no prior hysterectomy or cervical cancer,
* not pregnant,
* last Pap \>3 years, last co-test \>5 years, or last HPV alone test \>5 years,
* speak English or Spanish,
* has a working cellphone,
* NJ residency
* ED patient

Exclusion Criteria:

* currently pregnant (as diagnostic procedures for cervical cancer are often deferred during pregnancy);
* previous hysterectomy;
* previous diagnosis of cervical cancer;
* current menses

About the study

This study will assess the feasibility of implementing HPV self-sampling as a primary cervical cancer screening strategy for under-screened women in the emergency department (ED). Eligible participants will receive education and an HPV self-sampling kit to complete in the ED. Individuals with HPV-positive results will be guided to follow-up care at a local clinic.

What is being tested

• HPV Self-collection in the ED (behavioral)

Sponsor: Rutgers, The State University of New Jersey · Participants: 100 · Started: Oct 15, 2026

Contact the study team

• Sara Heinert, PhD, MPH · Phone: (732) 235-7872

Official record on ClinicalTrials.gov — NCT07657104

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.